ABOS - Acumen Pharmaceuticals GAAP EPS of -$0.25 in-line August, 15 2022 04:18 PM Acumen Pharmaceuticals Inc. Acumen Pharmaceuticals press release ( NASDAQ: ABOS ): Q2 GAAP EPS of -$0.25 in-line. Cash Balance. As of June 30, 2022, cash, cash equivalents and marketable securities totaled $209.9 million For further details see: Acumen Pharmaceuticals GAAP EPS of -$0.25 in-line